February 29, 2024

PHILADELPHIA, Pa. , Feb. 8, 2024 /PRNewswire/ -- A securities fraud lawsuit has been filed against BioVie Inc. ("BioVie" or the "Company") (NASDAQ: BIVI). The lawsuit is captioned Olmstead v. BioVie Inc. et al., No. 3:24-cv-00035 (D. Nev.), and is filed on behalf of purchasers of BioVie's securities between August 5, 2021 and November 29, 2023, inclusive (the "Class Period").

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.